A Randomized Trial to Slow the Progression of Diabetes

NACompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

October 19, 2019

Primary Completion Date

June 8, 2023

Study Completion Date

June 11, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

Diabetes Management Package (DMP)

"M-POWER app: A one-stop portal to monitor diabetes self-management activities and progress. The app syncs and displays relevant data from study devices and apps.~GlycoLeap: A 24-week, digitally-delivered education and behavior change program for T2DM patients.~4 study devices with accompanying apps to aid in diabetes self-management: weighing scale, pedometer, glucometer, and pill tracker.~Recommended activities:~* Complete all 24 GlycoLeap lessons and quizzes~* Weight Monitoring: Weigh at least once a week.~* Physical Activity: At least 150 minutes of moderate-to-vigorous activity per week, targeting at least 420 Fitbit active minutes per week.~* Blood Glucose Monitoring: At least three post-meal measurements within 4.0-10.0 mmol/L per week, with each reading taken on different days.~* Medication: Take medications as prescribed."

BEHAVIORAL

M-POWER Rewards

A financial incentive program were participants can earn up to 516 M-Points (1 M-Point is equivalent to S$1) over the one-year study period for performing specific activities according to recommendations that are meant to improve glycemic control and for achieving HbA1c and weight loss goals. M-Points can be reimbursed in the form of financial rebates for approved non-inpatient healthcare-related expenses incurred during the study period.

Trial Locations (1)

169857

Duke-NUS Medical School, Singapore

All Listed Sponsors
collaborator

National Medical Research Council (NMRC), Singapore

OTHER_GOV

collaborator

SingHealth Polyclinics

OTHER

collaborator

Singapore General Hospital

OTHER

collaborator

Changi General Hospital

OTHER

lead

Duke-NUS Graduate Medical School

OTHER

NCT03800680 - A Randomized Trial to Slow the Progression of Diabetes | Biotech Hunter | Biotech Hunter